InvestSMART

Immutep Limited (ASX: IMM) - Announcements

Current share price for IMM : $0.032 0.001 (3.03%)+

ASX company news and announcements for Immutep Limited (IMM) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Immutep Limited (IMM) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Immutep Limited (IMM), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Immutep Limited (IMM)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$47 Change of Director's Interest Notice - P Meyers 1 Oct 2026 8:16AM $0.034 $0.032 fallen by 5.88%
$47 Application for quotation of securities - IMM 1 Oct 2026 8:15AM $0.034 $0.032 fallen by 5.88%
$47 Immutep receives Australian R&D Tax Incentive 30 Sep 2026 9:25AM $0.034 $0.032 fallen by 5.88%
$47 Change to American Depositary Share Ratio 21 Sep 2026 12:39PM $0.040 $0.032 fallen by 20%
$47 Immutep Outlines Focused Development Strategy for Efti 11 Sep 2026 9:01AM $0.044 $0.032 fallen by 27.27%
$47 S&P DJI Announces September 2026 Quarterly Rebalance 4 Sep 2026 5:10PM $0.048 $0.032 fallen by 33.33%
$47 Appendix 4E & 2026 Full Year Statutory Accounts 31 Aug 2026 9:12AM $0.050 $0.032 fallen by 36%
$47 Immutep Corporate Presentation 20 Aug 2026 7:58AM $0.051 $0.032 fallen by 37.25%
$47 Immutep Quarterly Activities Report and Appendix 4C 30 Jul 2026 8:24AM $0.047 $0.032 fallen by 31.91%
$47 Abstract Accepted for Presentation at ESMO Congress 2026 24 Jul 2026 9:01AM $0.050 $0.032 fallen by 36%
$47 Fourth U.S. Patent Secured for Efti and PD-1 Combination 14 Jul 2026 12:11PM $0.055 $0.032 fallen by 41.82%
$47 TACTI-004 Update & Positive Mature Data from INSIGHT-003 13 Jul 2026 9:38AM $0.051 $0.032 fallen by 37.25%
$47 Ceasing to be a substantial holder 1 Jul 2026 8:14AM $0.053 $0.032 fallen by 39.62%
$47 Becoming a substantial holder 17 Jun 2026 8:22AM $0.046 $0.032 fallen by 30.43%
$47 Ceasing to be a substantial holder 16 Jun 2026 8:16AM $0.048 $0.032 fallen by 33.33%
$47 Becoming a substantial holder 15 Jun 2026 8:19AM $0.047 $0.032 fallen by 31.91%
$47 Ceasing to be a substantial holder 10 Jun 2026 8:19AM $0.047 $0.032 fallen by 31.91%
$47 Ceasing to be a substantial holder 9 Jun 2026 5:58PM $0.047 $0.032 fallen by 31.91%
$47 Change in substantial holding 9 Jun 2026 8:13AM $0.048 $0.032 fallen by 33.33%
$47 Becoming a substantial holder 9 Jun 2026 8:12AM $0.048 $0.032 fallen by 33.33%
$47 Change in substantial holding 4 Jun 2026 5:30PM $0.050 $0.032 fallen by 36%
$47 Immutep Presents Positive IMP761 Phase I Data at EULAR 2026 4 Jun 2026 8:23AM $0.051 $0.032 fallen by 37.25%
$47 Change in substantial holding 29 May 2026 5:03PM $0.053 $0.032 fallen by 39.62%
$47 Efti immune activation associated with improved survival 28 May 2026 9:18AM $0.054 $0.032 fallen by 40.74%
$47 Change in substantial holding 27 May 2026 6:51PM $0.054 $0.032 fallen by 40.74%

1 - 25 of 783 results

Page 1 of 32

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.